The study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in invasive disease-free survival
Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
The high-performance polymer’s transparency and biocompatibility support precise implantation and long-term reliability
OERIS offers extended antiemetic coverage through a single injection that effectively prevents both acute and delayed CINV for up to five days
Dragon Copilot integrates generative AI, ambient listening, and natural language processing (NLP) to capture and document care directly
Subscribe To Our Newsletter & Stay Updated
